NCT00450775View on ClinicalTrials.gov

Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars

PHASE4CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Scars

Interventions

DRUG

Dermatix Q

Dermatix Q applied twice daily

Trial Locations (1)

33134

Dadeland Dermatology, Coral Gables

Sponsors

Lead Sponsor

Innovative Medical

All Listed Sponsors

lead

Innovative Medical

INDUSTRY

NCT00450775 - Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars | Biotech Hunter | Biotech Hunter